These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 16782906

  • 21. Treatment of oligodendroglioma: an update.
    Paleologos NA, Cairncross JG.
    Neuro Oncol; 1999 Jan; 1(1):61-8. PubMed ID: 11550303
    [Abstract] [Full Text] [Related]

  • 22. [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
    Bouffet E, Mornex F, Jouvet A, Thiesse P, Mertens P, Helfre S, Sindou M, Bret P.
    Bull Cancer; 1997 Oct; 84(10):951-6. PubMed ID: 9435796
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. PCV for anaplastic oligodendrogliomas: back to the future or a step backwards? A point/counterpoint discussion.
    Villano JL, Wen PY, Lee EQ, Nayak L, Reardon DA, Rosenfeld MR.
    J Neurooncol; 2013 May; 113(1):143-7. PubMed ID: 23479035
    [No Abstract] [Full Text] [Related]

  • 25. Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors.
    Walker C, Haylock B, Husband D, Joyce KA, Fildes D, Jenkinson MD, Smith T, Broome J, du Plessis DG, Warnke PC.
    Neurology; 2006 Jun 13; 66(11):1661-7. PubMed ID: 16769937
    [Abstract] [Full Text] [Related]

  • 26. Medical Research Council adjuvant trial in high-grade gliomas.
    Chamberlain MC, Jaeckle KA.
    J Clin Oncol; 2001 Oct 01; 19(19):3997-9. PubMed ID: 11579124
    [No Abstract] [Full Text] [Related]

  • 27. Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri.
    Schiff D.
    Neurology; 2003 Aug 12; 61(3):425; author reply 425. PubMed ID: 12913224
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma.
    Paleologos NA, Macdonald DR, Vick NA, Cairncross JG.
    Neurology; 1999 Sep 22; 53(5):1141-3. PubMed ID: 10496285
    [Abstract] [Full Text] [Related]

  • 31. Neuro-oncology: anaplastic oligodendrogliomas-value of early chemotherapy.
    Ducray F, Idbaih A.
    Nat Rev Neurol; 2013 Jan 22; 9(1):7-8. PubMed ID: 23229404
    [No Abstract] [Full Text] [Related]

  • 32. Chemoradiation and adjuvant chemotherapy for glioblastoma: why does so much therapy yield so little improvement in survival?
    Loeffler JS, Shrieve DC, Coleman CN.
    Int J Radiat Oncol Biol Phys; 1995 Sep 30; 33(2):531-3. PubMed ID: 7673044
    [No Abstract] [Full Text] [Related]

  • 33. Aggressive oligodendroglioma: a chemosensitive tumor.
    Cairncross JG.
    Recent Results Cancer Res; 1994 Sep 30; 135():127-33. PubMed ID: 8047688
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951.
    Idbaih A, Dalmasso C, Kouwenhoven M, Jeuken J, Carpentier C, Gorlia T, Kros JM, French P, Teepen J, Broët P, Delattre O, Mokhtari K, Sanson M, Delattre JY, van den Bent M, Hoang-Xuan K.
    J Neurooncol; 2011 Jun 30; 103(2):221-30. PubMed ID: 20820870
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of adjuvant therapy with procarbazine, MCNU, and vincristine for oligodendroglial tumors.
    Wakabayashi T, Kajita Y, Mizuno M, Nagasaka T, Yoshida J.
    Neurol Med Chir (Tokyo); 2001 Mar 30; 41(3):115-9; discussion 119-20. PubMed ID: 11372553
    [Abstract] [Full Text] [Related]

  • 37. Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study.
    Guillaume DJ, Doolittle ND, Gahramanov S, Hedrick NA, Delashaw JB, Neuwelt EA.
    Neurosurgery; 2010 Jan 30; 66(1):48-58; discussion 58. PubMed ID: 20023537
    [Abstract] [Full Text] [Related]

  • 38. PCV chemotherapy for oligodendroglioma: response analyzed on T2 weighted-MRI.
    Diabira S, Rousselet MC, Gamelin E, Soulier P, Jadaud E, Menei P.
    J Neurooncol; 2001 Oct 30; 55(1):45-50. PubMed ID: 11804282
    [Abstract] [Full Text] [Related]

  • 39. Radiation and chemotherapy improve outcome in oligodendroglioma.
    Allison RR, Schulsinger A, Vongtama V, Barry T, Shin KH.
    Int J Radiat Oncol Biol Phys; 1997 Jan 15; 37(2):399-403. PubMed ID: 9069313
    [Abstract] [Full Text] [Related]

  • 40. Semi-quantification of methionine uptake and flair signal for the evaluation of chemotherapy in low-grade oligodendroglioma.
    Tang BN, Sadeghi N, Branle F, De Witte O, Wikler D, Goldman S.
    J Neurooncol; 2005 Jan 15; 71(2):161-8. PubMed ID: 15690133
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.